Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seventeen research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, fourteen have assigne

One invests in growth through public safety tech; the other generates steady cash from iconic consumer brands. Their valuation gap reveals which may offer better 2026 upside.

One invests in growth through public safety tech; the other generates steady cash from iconic consumer brands. Their valuation gap reveals which may offer better 2026 upside.

Price-action only: Axon Enterprise Inc. (AXON) movements set the tone for institutional models. The Technical Signals Behind (AXON) That Institutions Follow

Armstrong Advisory Group Inc. raised its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 4,439.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 34,819 shares of the biotechnology company

View the basic AXON option chain and compare options of Axon Enterprise, Inc. on Yahoo Finance.

The Cherokee County Board of Commissioners will decide later this month whether to to approve a consolidated Cherokee Sheriff’s Office technology contract with Axon Enterprise Inc. for $37 million over

Castle Rock Wealth Management LLC increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 949.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,955 shares of the biotechnology company

Wedmont Private Capital lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 5,927.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 43,517 shares of the biotechnology company

WoodTrust Financial Corp grew its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 252.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,676 shares of the biotechnology company

First Heartland Consultants Inc. grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 2,538.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,586 shares

Mn Services Vermogensbeheer B.V. grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 5,571.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,262,110 shares of the biotechnology company

GAMMA Investing LLC lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 6,472.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 110,359 shares of the biotechnology company